Elizabeth Holmes pointed Tuesday to attorney advice to justify statements from Theranos about its technology and processes that prosecutors say were misrepresentations constituting criminal fraud.

In the Theranos founder’s third day of the testimony, Holmes said lawyers steered the company away from deploying its blood-testing technology in Walgreens Co. stores and counseled executives not to disclose the use of commercial blood-testing devices in their partnership with the pharmacy chain.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]